Infectious Disease Vaccination for People Who Use Drugs

There is an increased urgency to provide HAV/HBV vaccination and HIV/HCV screening/treatment for patients who use drugs due to their risk of infection. Nonetheless, patients presenting for care may have other priorities, and providers may not be prepared to offer vaccination. Additionally, other factors complicate screening, vaccination, and treatment, such as difficulty obtaining labs, tracking vaccination records, or contacting patients for follow up. This program will seek to describe a patient who presented for treatment of substance use disorder and obtained vaccination for HAV/HBV.

Registration: https://www.eventbrite.com/e/445491395757

Credit: CME

Cost: None


Presenter: Jennifer Aldrich, MD

Dr. Jennifer Aldrich is a Professor of Clinical Medicine at Lewis Katz School of Medicine, Temple University. Her work involves managing HIV, HBV, and HCV care for hundreds of inmates in the state correctional system, as well as developing a gender affirming medical outpatient practice in coordination with Temple’s surgical program. In this latter role she also sees patients at Philadelphia’s Mazzoni Center for LGBTQ care.  She regularly brings students and residents with her and teaches about LGBTQ+ and corrections medicine.

Dr. Aldrich graduated from the University of Rochester School of Medicine and Dentistry, and then pursued her training in Internal Medicine and Infectious Diseases at the Hospital of the University of Pennsylvania. She previously served as the Director for HIV Clinical Services for the Philadelphia Department of Public Health.

Dr. Aldrich is a co-chair of Temple Health System’s LGBTQ Alliance Task Force, the faculty co-advisor for the LKSOM student-run clinic, and she serves on the Temple IRB representing prisoner interests. She has previously served as the Medical Director for Siloam Wellness, and Vice Chair of the Board of MANNA, both AIDS service organizations.


CME Program Code:  23257

Target Audience:  Physicians, Physician Assistants, and Certified Registered Nurse Practitioners who have completed the didactic training of the MOUD Preceptor program.

Learning Objectives:  Describe a case that illustrates how giving residents experience of providing care to patients with substance use disorders outside of traditional treatment settings benefits learners, patients, and communities.

ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Drexel University College of Medicine and the Health Federation of Philadelphia. The Drexel University College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement: The Drexel University College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA: This program is eligible for 1.0 credits in Category 2A of the American Osteopathic Association.  

FACULTY DISCLOSURE STATEMENT  
It is the policy of Drexel University College of Medicine to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational programs. Speakers at continuing medical education activities are required to disclose to the audience any relevant commercial interest (which is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients). Any conflicts of interest must be resolved prior to the presentation and announced to the audience. The intent of this disclosure is to allow participants to form their own judgments about the educational content of this activity and determine whether the speaker’s commercial interests influenced the presentation. In addition, speakers are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentation. 

FACULTY DISCOSURE: Jennifer Aldrich has no financial relationships to disclose.

CME PLANNING COMMITTEE DISCLOSURES: Debra D’Alessandro, MPH, Jennifer Kolker, MPH, and Andrew Best Jr., DPA, MPA, MSS, LSW have no commercial relationships to disclose.  

Requirements to receive credits: Continuing education credits will be awarded to those who sign the discipline-specific sign-in sheet, attend the entire program and complete a program evaluation. 

This program is funded in part by the Philadelphia Department of Public Health.

Date
November 10, 2022
3:00 pm — 4:00 pm
Training Type Wound and Skin and Soft Tissue Morbidity and Mortality Review Workgroup